Nanda Gruben

669 citations

9 papers · 551 indexed · h-index 8

Impact in

Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
Physiology top 10%
- Adipose Tissue and Metabolism
- Diet and metabolism studies

Papers in ⓘ

Epidemiology 9
- Liver Disease Diagnosis and Treatment 8
- Adipokines, Inflammation, and Metabolic Diseases 4
Biochemistry 1

Co-authors: Debby P.Y. Koonen (9 shared papers)Marten H. Hofker (8 shared papers)Ronit Shiri‐Sverdlov (6 shared papers)Niels Kloosterhuis (7 shared papers)Alain de Bruin (5 shared papers)Pascal P. H. Hommelberg (3 shared papers)Sameh A. Youssef (2 shared papers)Fareeba Sheedfar (3 shared papers)
Journals: Hepatology (2 papers)Nutrition and Diabetes (1 paper)Aging (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)Atherosclerosis (1 paper)
Partner nations: Netherlands United States Italy

In The Last Decade

Nanda Gruben

9 papers receiving 542 citations

Peers

Countries citing papers authored by Nanda Gruben

Since Specialization

Citations

This map shows the geographic impact of Nanda Gruben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanda Gruben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanda Gruben more than expected).

Fields of papers citing papers by Nanda Gruben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanda Gruben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanda Gruben. The network helps show where Nanda Gruben may publish in the future.

Co-authors

The 25 scholars most cited alongside Nanda Gruben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nanda Gruben Line = papers co-authored together Nanda Gruben links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work
1	High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice Aging ·Roel A. van der Heijden, Fareeba Sheedfar, Martine C. Morrison, Pascal P. H. Hommelberg, Danny Kor, Niels Kloosterhuis, Nanda Gruben, Sameh A. Youssef, Alain de Bruin, Marten H. Hofker, Robert Kleemann, Debby P.Y. Koonen, Peter Heeringa	2015	227
2	Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Nanda Gruben, Ronit Shiri‐Sverdlov, Debby P.Y. Koonen, Marten H. Hofker	2014	122
3	The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis Molecular Metabolism ·Andries Heida, Nanda Gruben, Leen Catrysse, Martijn Koehorst, Mirjam H. Koster, Niels Kloosterhuis, Albert Gerding, Rick Havinga, Vincent W. Bloks, Laura Bongiovanni, Justina C. Wolters, Theo van Dijk, Geert Loo, Alain de Bruin, Folkert Kuipers, Debby P.Y. Koonen, Bart van de Sluis	2021	55
4	Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity Nutrition and Diabetes ·Marcel G. M. Wolfs, Nanda Gruben, Sander S. Rensen, Froukje J. Verdam, Júlia María D’Andréa Greve, Ann Driessen, Cisca Wijmenga, Wim A. Buurman, Lude Franke, Ludger Scheja, Debby P.Y. Koonen, Ronit Shiri‐Sverdlov, Timon W. van Haeften, Marten H. Hofker, Jingyuan Fu	2015	47
5	Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice PLoS ONE ·Nanda Gruben, Marcela Aparicio Vergara, Niels Kloosterhuis, Henk F. van der Molen, Stefan Stoelwinder, Sameh A. Youssef, Alain de Bruin, Dianne J. Delsing, Jan Albert Kuivenhoven, Bart van de Sluis, Marten H. Hofker, Debby P.Y. Koonen	2014	36
6	Tumor Necrosis Factor Receptor 1 Gain-of-Function Mutation Aggravates Nonalcoholic Fatty Liver Disease but Does Not Cause Insulin Resistance in a Murine Model Hepatology ·Marcela Aparicio-Vergara, Pascal P. H. Hommelberg, Marijke Schreurs, Nanda Gruben, Rinke Stienstra, Ronit Shiri‐Sverdlov, Niels Kloosterhuis, Alain de Bruin, Bart van de Sluis, Debby P.Y. Koonen, Marten H. Hofker	2012	36
7	Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice Atherosclerosis ·Anouk Funke, Marijke Schreurs, Marcela Aparicio-Vergara, Fareeba Sheedfar, Nanda Gruben, Niels Kloosterhuis, Ronit Shiri‐Sverdlov, Albert K. Groen, Bart van de Sluis, Marten H. Hofker, Debby P.Y. Koonen	2013	20
8	Cholesterol-Induced Hepatic Inflammation Does Not Underlie the Predisposition to Insulin Resistance in Dyslipidemic Female LDL Receptor Knockout Mice Journal of Diabetes Research ·Nanda Gruben, Anouk Funke, Niels Kloosterhuis, Marijke Schreurs, Fareeba Sheedfar, Rick Havinga, Sander M. Houten, Ronit Shiri‐Sverdlov, Bart van de Sluis, Jan Albert Kuivenhoven, Debby P.Y. Koonen, Marten H. Hofker	2015	7
9	Impaired Shedding of TNF Receptor 1 Aggravates High Fat Diet Induced Non-Alcoholic Fatty Liver Disease But Does Not Cause Insulin Resistance in Mice Hepatology ·Pascal P. H. Hommelberg, Marcela Aparicio-Vergara, Marijke Schreurs, Nanda Gruben, Rinke Stienstra, Ronit Shiri‐Sverdlov, Niels Kloosterhuis, Alain de Bruin, Bart van de Sluis, Debby P.Y. Koonen, Marten H. Hofker	2012	1

About Nanda Gruben

Nanda Gruben is a scholar working on Epidemiology, Biochemistry, Hepatology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 9 papers that have together received 551 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Lipid metabolism and disorders (2 papers), Cholesterol and Lipid Metabolism (2 papers), Diet, Metabolism, and Disease (1 paper), NF-κB Signaling Pathways (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Epidemiology (357 citations), Physiology (195 citations), Endocrinology, Diabetes and Metabolism (116 citations), Endocrine and Autonomic Systems (38 citations) and Hepatology (38 citations). Nanda Gruben has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Debby P.Y. Koonen, Marten H. Hofker, Ronit Shiri‐Sverdlov, Niels Kloosterhuis, Alain de Bruin, Pascal P. H. Hommelberg, Sameh A. Youssef, Fareeba Sheedfar, Robert Kleemann and Martine C. Morrison. Their work appears in journals such as Hepatology, Nutrition and Diabetes, Aging, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact